SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 06/19/2026 at 12:31, 1 month 16 days ago

Communiqué de presse : Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple
Sanofi obtient l'approbation japonaise pour Sarclisa SC, traitement sous-cutané du myélome multiple, offrant commodité et efficacité. Possibilité d'administration via injecteur portable

Japon Sanofi Myélome Multiple Approbation Sarclisa
PRESS RELEASE

published on 06/19/2026 at 12:31, 1 month 16 days ago

Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
Sanofi's Sarclisa subcutaneous formulation approved in Japan for multiple myeloma patients, offering a convenient treatment option via OBI administration and manual injection

Japan Sanofi Multiple Myeloma Sarclisa Subcutaneous Formulation
BRIEF

published on 06/19/2026 at 10:05, 1 month 16 days ago

Sanofi et HEC Paris lancent des bourses pour les futurs leaders de la santé

Management Sanofi Bourses Leaders Santé HEC Paris
BRIEF

published on 06/19/2026 at 10:05, 1 month 16 days ago

Sanofi and HEC Paris launch scholarships for future healthcare leaders

Scholarships Management Sanofi HEC Paris Health Leaders
PRESS RELEASE

published on 06/19/2026 at 10:00, 1 month 16 days ago

Communiqué de presse : Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé
Sanofi et HEC Paris lancent la 'Sanofi MBA Life Sciences Scholarship' pour soutenir les futurs leaders de la santé. Programme de bourses pour le MBA HEC Paris

Santé Sanofi Bourses Leaders HEC Paris
BRIEF

published on 06/13/2026 at 00:14, 1 month 22 days ago

Le Tzield de Sanofi obtient l'approbation de la FDA pour le traitement du diabète de type 1

Sanofi Diabète De Type 1 Approbation Tzield Approbation Accélérée De La FDA Étude PROTECT
BRIEF

published on 06/13/2026 at 00:14, 1 month 22 days ago

Sanofi's Tzield Gains FDA Approval for Type 1 Diabetes Therapy

Sanofi FDA Accelerated Approval Type 1 Diabetes Tzield Approval PROTECT Study
PRESS RELEASE

published on 06/13/2026 at 00:09, 1 month 22 days ago

Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Sanofi's Tzield receives US FDA approval as first disease-modifying therapy for stage 3 type 1 diabetes, targeting autoimmune attack against insulin-producing beta cells

FDA Approval Sanofi Type 1 Diabetes Tzield Autoimmune Therapy
BRIEF

published on 06/04/2026 at 10:12, 2 months 1 day ago

Sanofi lance son plan mondial d'achat d'actions pour les employés à l'horizon 2026.

Actionnariat Plan D'achat D'actions Sanofi Actions Des Employés Initiative Mondiale
BRIEF

published on 06/04/2026 at 10:12, 2 months 1 day ago

Sanofi Introduces 2026 Global Employee Stock Purchase Plan

Shareholding Stock Purchase Plan Sanofi Employee Shares Global Initiative

Published on 08/05/2026 at 13:30, 16 minutes ago

Nextech3D.ai Signs Strategic Partnership with F2B Services to Drive AI Software Adoption, Expand LED Display Opportunities and Accelerate Event Technology Growth
Published on 08/05/2026 at 13:30, 16 minutes ago

International Battery Metals Announces First Quarter Fiscal 2027 Financial Results Conference Call and Webcast
Published on 08/05/2026 at 13:00, 46 minutes ago

Global Education Communities Corp. Announces Executive Appointments and Leadership Updates
Published on 08/05/2026 at 13:00, 46 minutes ago

Galway Metals Reports Broad Gold Intercepts from Southwest Deposit, Including 2.6 g/t Over 48.0 Metres
Published on 08/05/2026 at 13:00, 46 minutes ago

Rocky Shore Drills 15.0 metres of 2.04 g/t Au Including 5.0 metres of 3.85 g/t Au, Announces Discovery of the Lucky 13 Gold Zone

View all ACCESSWIRE

Published on 08/05/2026 at 13:23, 23 minutes ago

Application for Block Listing
Published on 08/05/2026 at 13:00, 46 minutes ago

Nebius appoints Lindsey Irvine as Chief Marketing Officer
Published on 08/05/2026 at 12:25, 1 hour 21 minutes ago

Infosys and Metsä Group Expand Strategic Collaboration to Drive AI-led IT Transformation
Published on 08/05/2026 at 11:40, 2 hours 6 minutes ago

INTCO Medical Recognized in S&P Global Sustainability Yearbook (China Edition) 2025 for ESG Progress
Published on 08/05/2026 at 11:35, 2 hours 11 minutes ago

OUKITEL EP2500 Launches: Redefining Balcony Energy Storage with an Advanced All-in-One System

View all EQS

Published on 08/05/2026 at 13:33, 13 minutes ago

Actualisation du document d'enregistrement universel 2025
Published on 08/04/2026 at 19:16, 18 hours 30 minutes ago

Covivio - 2026 Half-year financial report
Published on 08/04/2026 at 19:16, 18 hours 30 minutes ago

Covivio - Rapport financier semestriel 2026
Published on 08/04/2026 at 18:32, 19 hours 14 minutes ago

Capital et droits de vote au 31 juillet 2026
Published on 08/04/2026 at 18:32, 19 hours 14 minutes ago

Total number of voting rights and shares making up the share capital at July 31, 2026

View all LES ECHOS COMFI WIRE

News